Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Operating Margin (2018 - 2025)

Bicycle Therapeutics' Operating Margin history spans 8 years, with the latest figure at 349.61% for Q4 2025.

  • For Q4 2025, Operating Margin rose 217439.0% year-over-year to 349.61%; the TTM value through Dec 2025 reached 75.36%, up 72736.0%, while the annual FY2025 figure was 75.36%, 51960.0% up from the prior year.
  • Operating Margin reached 349.61% in Q4 2025 per BCYC's latest filing, up from 558.64% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 349.61% in Q4 2025 to a low of 2965.82% in Q2 2025.
  • Average Operating Margin over 5 years is 889.92%, with a median of 781.61% recorded in 2023.
  • The largest YoY upside for Operating Margin was 217439bps in 2025 against a maximum downside of -246751bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 1126.5% in 2021, then soared by 66bps to 383.46% in 2022, then tumbled by -165bps to 1017.35% in 2023, then tumbled by -79bps to 1824.78% in 2024, then skyrocketed by 119bps to 349.61% in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Operating Margin are 349.61% (Q4 2025), 558.64% (Q3 2025), and 2965.82% (Q2 2025).